Navigation Links
ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer
Date:1/13/2014

SHANGHAI, Jan. 13, 2014 /PRNewswire/ -- ShangPharma Corporation is pleased to announce that Dr. Mitchell Reff has joined the company as Chief Biologics Officer. Dr. Reff brings over 30 years of research and development experience in the biopharmaceutical industry. Dr. Reff's appointment further strengthens the world-class technical capabilities of ChemPartner's Biologics Division and offers Pharmaceutical and Biotechnology companies from around the world first-rate strategic and technical expertise to discover and manufacture novel first-in-class and best-in-class biologic clinical development candidates to advance into the Pharmaceutical and Biotechnology company pipelines.

Dr. Reff received his Ph.D. in Medical Microbiology from Stanford University School of Medicine, and his Bachelor's degree in Chemistry from Massachusetts Institute of Technology. This was followed by a  Postdoctoral Fellowship at Harvard Medical School, and  a position at the National Cancer Institute. Dr. Reff then spent 8 years at SmithKline Laboratories working on gene expression in mammalian cells and protein engineering. After that, he joined Idec Pharmaceuticals as head of molecular biology in 1990. Dr. Reff had a distinguished 21 year career at Idec, and later at Biogen Idec. He was Vice President Discovery Oncology at Biogen Idec running multiple bicoastal oncology groups developing small molecule and recombinant protein therapeutic molecules for oncology and delivered 6 novel oncology drugs into clinical trials in 5 years.

In early 1990s, Dr. Reff was Project Leader targeting B cell lymphoma, building and expressing the chimeric mouse-human anti-CD20 monoclonal antibody (Rituxan), the first monoclonal antibody approved to treat a tumor. Dr. Reff led the efforts from discovery until Rituxan entered its pivotal clinical trial.

Dr. Reff is well-recognized in the pharmaceutical and resea
'/>"/>

SOURCE ShangPharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ShangPharma Corporation Announces Completion of Merger
2. ShangPharma Corporation Announces Extraordinary General Meeting of Shareholders
3. ShangPharma Announces Third Quarter 2012 Results
4. ShangPharma to Report Third Quarter 2012 Financial Results on November 20, 2012
5. ShangPharma and Harbour Antibodies Announce Licensing Agreement
6. ShangPharma Announces Second Quarter 2012 Results
7. ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012
8. ShangPharma Independent Committee Appoints Financial Advisor
9. ShangPharma Independent Committee Appoints Chairman and Legal Counsel
10. ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS
11. ShangPharma Announces First Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 6, 2015  LumiThera Inc., a medical device ... treatment for ocular disorders and disease, today announced Retired ... LumiThera,s Advisory Board to assist in the company,s mission ... "Norm" Dicks was the U.S. Representative for ... and 2013. He is a member of the Democratic ...
(Date:5/6/2015)... 6, 2015 NVSSoft, a ... named a "Cool Vendor" by top IT research firm Gartner ... Gartner defines a "Cool Vendor" as a company ... intriguing. The report highlights that, "as innovation gains ... emerging markets should look at local technologies and services, which ...
(Date:5/6/2015)... California , May 6, 2015 ... Pharma and Life Sciences Technology Solution Providers 2015 ... List for Pharma and Life Sciences Technology Solution Providers ... Life Science and Healthcare Organizations CIO Review ... Promising Pharma and Life Sciences Technology Solution Providers 2015. ...
Breaking Medicine Technology:Retired Congressman Norman Dicks Joins LumiThera's Advisory Team 2UAE-Based Software Developer Named by Gartner as a Cool Vendor 2UAE-Based Software Developer Named by Gartner as a Cool Vendor 3UAE-Based Software Developer Named by Gartner as a Cool Vendor 4CIO Review Selects Indegene for 20 Most Promising Pharma and Life Sciences Technology Solution Providers 2015 2
(Date:5/6/2015)... RPS Revolution - a game for the ... true Rock Paper Scissors game - is now taking ... storytelling and easy to learn rules from Rock Paper Scissors, ... favorite. RPS Revolution takes the best parts of ... are grouped in set of three called Trios. Trios like ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 MJNational LLC ... Mobile, (OTC: LGBI), Canna Bizcard ™ platform. This exciting ... in Investor Relations, Product Sales / Services. Now ... bring national awareness to products, services and ticker symbol ... marketing system. , MJNational LLC will provide managed support ...
(Date:5/6/2015)... 2015 Imprivata ® (NYSE: IMPR), ... David Ting will lead a discussion about the Internet ... and user authentication challenges, during Citrix Synergy ... focus on the benefits of creating a network of ... and patients can share information. It will also emphasize ...
(Date:5/6/2015)... May 06, 2015 On April 27, ... Plastic Surgery ,” compiled quotes about cosmetic surgery ... Aniston, pop singer Iggy Azalea, and Gwyneth Paltrow. For ... about having plastic surgery themselves; only a ... and its expectations of youth and beauty. (see: goo.gl/wSomih) ...
(Date:5/6/2015)... May 06, 2015 Qushanna Doby (20) was ... nearby drug treatment center in Florida while under the influence ... 4th. New surveillance tapes released by CBS4’s Peter D’Oench records ... baby. Doby’s child is around one year old. The drug ... shivering outside was not named. The residents polled by CBS ...
Breaking Medicine News(10 mins):Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 2Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 3Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Plastic Surgery: Sixteen Celebrities Offer their Opinion about Going Under the Knife 2Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2
... , , MISSION VIEJO, Calif., Sept. ... the parent company of the Ensign(TM) group of skilled nursing, rehabilitative ... of Directors has declared a quarterly cash dividend of $0.045 per ... 2009 to shareholders of record as of September 30, 2009. Ensign ...
... BOTHELL, Wash., Sept. 18 SCOLR Pharma, Inc. ... September 15, 2009, the NYSE Amex LLC (the "Exchange") accepted ... disclosed listing deficiency as set forth in Section 1003(a)(iii) of ... Company,s failure to maintain stockholder,s equity of at least $6,000,000 ...
... , , LAWRENCE, Mass., Sept. ... leading manufacturer of innovative dialysis products, today announced that home dialysis ... Road Trip" with the NxStage(R) System One(TM). As a portable ... opportunity to fit hemodialysis therapy into his own lifestyle and schedule. ...
... , , , , ... hip abnormalities, combined with advances in diagnostic imaging techniques and minimally ... chronic, misdiagnosed hip pain. , , Increasingly, ... of degenerative hip disease, get patients back to their chosen activities ...
... , Statement of Andy Stern, President of ... Andy Stern, President of the Service Employees International Union, ... extremists to silence working families by attacking progressive individuals and community ... of profound change for this country -- from kitchen tables to ...
... , , HAYWARD, Calif., Sept. ... global leader in the medical aesthetics market, today announced that it ... on Tuesday, September 29, 2009 at the Grand Hyatt New York ... for 10:30 a.m. Eastern Time on September 29, 2009. Stephen ...
Cached Medicine News:Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Health News:NxStage Patient Takes Dialysis Machine on Third Annual Patient Good-Will Tour 2Health News:NxStage Patient Takes Dialysis Machine on Third Annual Patient Good-Will Tour 3Health News:Early Diagnosis and Treatment of Hip Conditions is Focus of New Center 2Health News:Early Diagnosis and Treatment of Hip Conditions is Focus of New Center 3Health News:Early Diagnosis and Treatment of Hip Conditions is Focus of New Center 4Health News:Early Diagnosis and Treatment of Hip Conditions is Focus of New Center 5Health News:Working Women and Men Will Not Be Silenced by Right Wing Attack Dogs; SEIU Members and Other Working Americans Will Continue to Speak Out For the America We Believe In 2Health News:Solta Medical to Present at the Maxim Group Growth Conference 2
... imaging agent that is labeled with technetium ... and localization of regions of reversible myocardial ... infarction under exercise and rest conditions. Imaging ... or up to 4 hours after administration ...
Stainless Steel...
Triangle shape (3.0mm long) Tip with Sliding Inner Shaft, Squeeze Activates Shaft to Punch; overall length 130mm, in stainless steel...
Olive Shaped Tip Cannula With Straight Shaft; in stainless steel....
Medicine Products: